Ebola outbreak puts nimble treatment trial designs to the test.
Where this comes from
- Record sourced from PubMed, PMID 42207884.
- Also identified by DOI 10.1126/science.aej2010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Updated strategies for studying antivirals and antibodies will face logistical challenges on the ground.
Medical subject headings
- Hemorrhagic Fever, Ebola
- Antiviral Agents
- Disease Outbreaks
- Research Design